NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock. The split comes at a ratio of one post-split share for every 11 pre-split shares. Tyler, Texas-based NanoVibronix expects the split to go into effect at 4:05 p.m. on March 13, 2025. It plans for its common stock […]
Men's Health
Neuspera has positive sacral neuromod data
Neuspera Medical today announced six-month pivotal clinical trial data highlighting the efficacy of its battery-free percutaneous sacral neuromodulation (pSNM) system. Findings showed comparable efficacy with the pSNM system against traditional sacral neuromodulation (SNM) devices. it also aims to offer a significantly better patient experience for the treatment of urgency urinary incontinence (UUI). San Jose, California-based […]
UroMems reports positive outcomes in first-ever female-only study of smart implant for incontinence
UroMems announced that the entire treatment cohort in the first-of-its-kind study in female patients successfully reached its primary endpoints. Grenoble, France-based UroMems — which has its U.S. headquarters in Minneapolis — develops an implantable system called UroActive. Powered by a MyoElectroMechanical system (MEMS), UroActive goes into the urethral duct in men and bladder neck in […]
Valencia Technologies raises $35M for coin-sized neuromod device, picks new CEO
Valencia Technologies announced today that it received a strategic investment totaling up to $35 million and appointed a new CEO. The neuromodulation company focused on treating urinary incontinence named James D. Surek as its new CEO. Valencia plans to leverage its new capital and Surek’s commercial leadership experience to fuel the growth of its eCoin […]
Medtronic, Boston Scientific settle Axonics IP dispute
Medtronic and Axonics — now part of Boston Scientific — have confidentially settled their long-running IP dispute. Legal news sites, including Bloomberg Law, were the first to break the news this week. A Medtronic spokesperson provided the following statement to MassDevice today: “Medtronic and Boston Scientific are pleased to have reached a confidential settlement agreement that will resolve […]
Levee Medical raises $14M for urologic scaffold
Levee Medical announced today that it closed its Series B financing, bringing in proceeds of more than $14 million. The Durham, North Carolina-based company plans to use funds to accelerate the development of its Voro urologic scaffold. It designed the device to reduce post-prostatectomy urinary incontinence. Funds could support ongoing clinical studies, including an upcoming […]
Dentsply Sirona to consider strategic alternatives for Wellspect Healthcare business
Dentsply Sirona (Nasdaq:XRAY) announced today that it initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business. Wellspect provides bladder and bowel management care products. The business, situated in what Dentsply considers a $2 billion continence care space, delivered mid-to-high single-digit sales growth over the past couple of years. Simon Campion, Dentsply Sirona’s […]
BlueWind data highlights durability, safety of Revi neuromod
BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system. Outcomes from the pivotal OASIS study, published in the March 2025 issue of the Journal of Urology, highlighted high patient satisfaction and durability for the technology. Park City, Utah-based BlueWind designed Revi for implantation near the ankle during a single outpatient […]
Biobot Surgical wins CE mark for Mona Lisa surgical robot
Biobot Surgical announced today that it received CE mark for its Mona Lisa 2.0 surgical robotic platform for urology applications. Approval in Europe adds to existing approvals in the U.S., Australia and Singapore, according to a news release. The company says this milestone paves the way for the utilization of Mona Lisa 2.0 across 32 […]
NanoVibronix completes pilot study of UroShield
NanoVibronix (Nasdaq:NAOV) announced today that it completed the first phase of a randomized controlled trial for its UroShield device. Researchers at the University of Michigan completed the first phase of the trial for UroShield, a portable ultrasonic therapeutic device. UroShield utilizes patented low-intensity surface acoustic wave (SAW) technology. This allows for the creation of low-frequency […]
Andromeda Surgical announces first robot-assisted prostate procedures
Andromeda Surgical announced that a surgeon in Chile performed a robotic-assisted holmium laser enucleation of the prostate (HoLEP) with its platform. The company says this marks the world’s first robotic-assisted HoLEP procedure. Dr. Cristián Trucco of Universidad Católica performed the case via a tablet interface to kick off the ASTRA clinical trial. Trucco and Dr. […]
